Reckitt Benckiser Group plc
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RBGLY research report →
Companywww.reckitt.com
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands. It also provides analgesics; sore throat medications; and hair removal products under the Nurofen, Strepsils, and Veet brands.
- CEO
- Kristoffer Loe Licht
- IPO
- 2008
- Employees
- 37,900
- HQ
- Slough, GB
Price Chart
Valuation
- Market Cap
- $41.34B
- P/E
- 11.26
- P/S
- 2.81
- P/B
- 3.93
- EV/EBITDA
- 10.20
- Div Yield
- 9.77%
Profitability
- Gross Margin
- 60.70%
- Op Margin
- 32.37%
- Net Margin
- 25.23%
- ROE
- 38.45%
- ROIC
- 15.42%
Growth & Income
- Revenue
- $13.89B · -1.94%
- Net Income
- $3.11B · 118.25%
- EPS
- $0.96 · 134.80%
- Op Income
- $4.12B
- FCF YoY
- -22.31%
Performance & Tape
- 52W High
- $17.80
- 52W Low
- $12.27
- 50D MA
- $13.44
- 200D MA
- $15.68
- Beta
- 0.25
- Avg Volume
- 800.15K
Get TickerSpark's AI analysis on RBGLY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our RBGLY Coverage
We haven't published any research on RBGLY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate RBGLY Report →